Stage IIIA Breast Cancer Recruiting Phase 2 Trials for Decitabine (DB01262)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02957968Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast CaTreatment